A5036677201- Estrogen and related hormone effects
- Neuropeptides and Animal Physiology
- RNA modifications and cancer
- Renal and related cancers
- Lung Cancer Treatments and Mutations
- RNA Research and Splicing
- Renal cell carcinoma treatment
- Hippo pathway signaling and YAP/TAZ
- Bladder and Urothelial Cancer Treatments
- Fibroblast Growth Factor Research
- Proteoglycans and glycosaminoglycans research
- Cancer-related molecular mechanisms research
- Ovarian cancer diagnosis and treatment
- Growth Hormone and Insulin-like Growth Factors
- Urinary and Genital Oncology Studies
Shanghai Pulmonary Hospital
2025
Tongji University
2025
Central South University
2018-2023
Third Xiangya Hospital
2018-2023
NYU Langone Health
1998
GTx (United States)
1998
Objective: To investigate the effects of sampling methods on pathological assessment resected non-small cell lung cancer (NSCLC) specimen with tumor maximum diameter >3 cm after neoadjuvant therapy. Methods: NSCLC patients a large (diameter cm) that were therapy from June 2020 to July 2023 retrospectively collected in Department Pathology, Shanghai Pulmonary Hospital, Shanghai, China. Sampling bed performed accordance international and Chinese experts recommendations for resection specimens...
Abstract Thyroid carcinoma (THCA) is the most common malignancy in endocrine system. Long intergenic non‐coding RNA 2454 (LINC02454) exhibits an HMGA2‐like expression pattern, but their relationship and roles THCA are largely unknown. The present purpose was to delineate of LINC02454 progression its molecular mechanisms. We collected tissues from patients monitored patient survival. cell colony formation, migration, invasion were evaluated. Metastasis evaluated by examining EMT markers...